SS Innovations International Financial Ratios
NASDAQ: SSIIHealth CareMedical/Dental InstrumentsUSD
2.65-0.015 (-0.56%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
SS Innovations International ratio analysis
SS Innovations International earned a net margin of -28.5% in FY 2025, up from -92.7% a year earlier. Gross margin was 46.0% compared with a median of 12.3% over the prior 3 years. Return on equity reached -31.7%, meaning SS Innovations International generated -0.32 dollars of profit for every dollar of shareholders' equity.
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
SS Innovations International financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Price / sales | 25.27 | 64.53 | — | — | — | — | — | — | — | — |
| Price / book | 28.09 | 99.03 | — | — | — | — | — | — | — | — |
| Gross margin | 46.0% | 40.9% | 12.3% | 4.2% | — | — | — | — | — | — |
| Operating margin | -19.3% | -91.9% | -345.1% | -206.0% | — | — | — | — | — | — |
| Net margin | -28.5% | -92.7% | -355.4% | -223.8% | — | — | — | — | — | — |
| Free cash flow margin | -52.3% | -49.2% | -269.2% | -432.7% | — | — | — | — | — | — |
| Return on equity (ROE) | -31.7% | -142.3% | -105.9% | — | -253.5% | — | — | — | -1,026.5% | — |
| Return on assets (ROA) | -16.3% | -45.2% | -66.2% | -46.0% | -346.3% | -353.8% | -2,555.0% | -660.3% | -203.5% | -166.0% |
| Debt / equity | — | — | 0.05 | — | — | — | — | — | — | — |
| Current ratio | 1.86 | 1.29 | 2.53 | 0.53 | 1.42 | 0.14 | 0.03 | 0.11 | 1.13 | 0.38 |
| Revenue growth | 105.7% | 251.5% | 309.1% | — | — | — | — | — | — | — |